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ABSTRACT 
The repeated administration of the hypolipidemic agent Su-13 437 (nafenopin) to 
neonatal rats roughly doubled the number of peroxisomes in the liver tissue and 
caused a  sixfold volumetric expansion of the peroxisomal compartment.  During 
the proliferative response, the size-distribution of the peroxisomes was reversibly 
altered,  enlarged  particles  appearing in numbers varying according  to the  dose 
given. By means of a new method for quantitative autoradiography, it was shown 
that (a) the concentration of silver grains over peroxisomes was comparable to that 
found over the endoplasmic reticulum; (b) the peak incorporation of [aH]arginine 
into the peroxisomes was delayed in comparison with that into the endoplasmic 
reticulum; (c) the label, once incorporated into the expanding peroxisomal com- 
partment, displayed the same shift to large particles as did the whole population. 
These  results  are  compatible  with  the  biosynthetic  pathway  for  peroxisomal 
catalase proposed earlier  (cf. reference  12),  and with  the  notion  that the  drug- 
induced size-shift might have resulted from progressive growth of a particular class 
of peroxisomes formed in the presence of the agent. Evidence is presented to show 
that  during  the  recovery period  the  larger peroxisomes are  removed preferen- 
tially. 
In a  series of reports, we  have shown  that  two 
hypolipidemic  drugs  of  the  a-aryloxyisobutyric 
acid  type,  clofibrate  (CPIB)  1 and  CIBA  Su-13 
437,  are endowed with the capacity to elicit  the 
induced state and to expand the peroxisomal com- 
partment of male rat liver parenchymal cells (24- 
1Abbreviations  used  in  this  paper:  CPIB,  clofibrate, 
Atromid S; DAB, diaminobenzidine; ER, endoplasmic 
reticulum;  PO,  peroxisome(s)  (microbody); RER, 
rough-surfaced endoplasmic reticulum, SER,  smooth- 
surfaced endoplasmic reticulum; Su-13 437, CIBA Su- 
13 437 (nafenopin). 
26,  69).  These  observations  were  subsequently 
confirmed  and  extended  by  several  research 
groups (reviewed in references 2, 30, 56, 70). The 
biosynthesis and precise metabolic function(s) of 
peroxisomes (microbodies) in normal or in experi- 
mentally altered mammalian cells are still not fully 
understood (12,  13,  56, 70), although in the past 
few years considerable progress has been achieved 
with  regard  to  the  biosynthesis  of  peroxisomal 
constituents (37,  38, 62). In addition, interest in 
the biology of peroxisomes has been rekindled by 
a  large  number  of  morphological  observations 
leading to the concept of the ubiquitous distribu- 
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(31). 
Inasmuch as the peroxisomes constitute a minor 
organelle in the rat hepatocyte (44, 78), the prolif- 
erating effect of compounds  of the  a-aryloxyiso- 
butyric  acid  type  on  these  structures  might  be 
utilized to investigate, in situ, some aspects of their 
biosynthesis in  quantitative terms.  In this report, 
the  proliferative  response  of  these  organelles  in 
the hepatocytes of immature  rats treated repeat- 
edly with Su-13 437 will be described in the light 
of a  morphometric, autoradiographic, and dimen- 
sional analysis. 
MATERIALS  AND  METHODS 
Animals 
Newborn albino rats (Wistar-derived) were used. The 
pregnant dams were fed standardized laboratory chow 
(Nafag no. 890) ad lib. 
Treatment  with Su-13 437 
Six newborn rats of similar weight were taken from 
each litter and divided into two groups of three. Su-13 
437  suspended  in  2%  carboxymethylcellulose  (CMC) 
was administered by intubation to the rats of the experi- 
mental groups in daily doses of 100 mg/kg body weight. 
The first dose was given on the 5th day postpartum, and 
the treatment continued for five consecutive days. The 
animals thus received the last dose of Su-13 437 at the 
age of 9 days (cf. Fig. 1). The other three animals from 
the same litter were  treated in the same manner with 
CMC and served as controls. 
Experimental Time Schedule 
As exemplified in Fig. 1, the observation period was 
divided into two parts.  During the first part  (progres- 
sion), five consecutive doses of Su-13 437 were adminis- 
tered to induce a high proliferation rate of peroxisomes 
(PO). The drug treatment was then discontinued. Dur- 
ing a subsequent 8-day recovery period, the disposal of 
excess PO was studied. The labeled amino acid was in- 
jected simultaneously with the third dose of the drug, 
and this point was designated as "zero" time (cf. arrow- 
head on the  abscissa of Fig.  10).  For the selection of 
labeling intervals, some  additional aspects  of the  bio- 
synthesis of  PO  were  considered.  It  has been  shown 
that the  specific activity  of an  important peroxisomal 
enzyme, catalase, reached a peak in the rough-surfaced 
endoplasmic reticulum  (RER)  20-30 min after the in- 
jection of a radioactive amino acid (27). The selection of 
20 min after the administration of the isotope as the first 
determination time made allowance for this biochemical 
finding.  By  injection of a  reusable  radioactive  amino 
acid, the half-life of hepatic PO has been estimated to 
be 3-4 days (55). Therefore, we chose the 3rd day after 
administration as a  further determination time; within 
the interval between the two selected times, further de- 
terminations were made at 6 h and 1.5 days. In addition, 
the tissue was analyzed 6 and 10 days after the injection 
of the label. As detailed in Fig.  1, the first three intervals 
(20 min, 6 h, and 1.5 days) fall within the progression 
phase, and the last three (3, 6, and 10 days) within the 
recovery period. At the end of the experiment (10 days), 
the animals were  17 days old. At the times stated, the 
rats were lightly anesthetized with ether and sacrificed by 
decapitation. 
Injection  of the Isotope 
Generally labeled DL-[SH]arginine monochloride (Ra- 
diochemical Centre, Amersham, England; specific activ- 
ity  1,200  mCi/mmol) was injected into the saphenous 
vein of three rats per determination time-point. Each rat 
received 2 mCi in 0.1 ml of distilled water. The site of 
injection was  covered  with  a  collodion  film.  Because 
drug-treated animals did not tolerate ether inhalation, 
they were anesthetized with a mixture of 95% CO2 and 
5% O~ given through a mask. 
Preparation  of the Tissue 
Although it has been claimed that formaldehyde is a 
more reliable fixative for autoradiographic purposes than 
osmium tetroxide (8, 52), the latter was chosen to permit 
comparison with earlier morphometric data published by 
our and other laboratories. The liver tissue was fixed for 
2  h  in  cold  phosphate-buffered  OsO4,  dehydrated  in 
acetone, and embedded in Araldite (Ciba-Geigy, Basel, 
Switzerland). The procedures adopted in preparing and 
staining thin sections are described below. It should be 
mentioned  that  the  morphometric  and  the  autoradi- 
ographic analyses were performed on the same animals. 
Autoradiographic  Procedures 
The bubble method described by Caro (10) was used 
and in our hands afforded reasonable reproducibility of 
grain monolayers. Thin sections (silver to gold,  corre- 
sponding to about 850/~ on the thickness scale of Salpe- 
ter and Bachmann (65) were prepared on a LKB-4800 
ultrotome (equipped with a diamond knife), transferred 
to 200-mesh grids covered with a collodion-carbon film, 
and  stained  with  aqueous  uranyl  acetate  (10  min  at 
60~  The grids were then attached to Parafilm ribbons 
adhering to  a  glass  slide  and  covered  with  Ilford  L4 
emulsion. Bubbling of the emulsion was performed with 
"Cyklon," an aquarium-type pump (J. Demuth, Waili- 
sellen, Switzerland). The coated grids were packed into 
Clay Adams boxes (Clay Adams, Inc., Div. of Becton, 
Dickinson,  Co.,  Parsippany,  N.J.)  in  the  presence of 
silica gel.  Finally, the boxes were placed in exsiccators 
containing silica gel and stored at 4~  During exposure, 
the desiccating material was replaced every 3 wk. Each 
box contained (a) experimental grids that served for the 
quantitative analysis of autoradiographs; (b) grids used 
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covered with nonradioactive sections for the assessment 
of the  background fog;  (d)  grids without sections for 
monitoring  the  time-course  of  the  background  fog 
development. The optimal exposure time was considered 
to be attained when the ratio of silver grains on grids 
covered  with  labeled  sections  (b)  to  silver grains  on 
grids without sections (d) was maximal. This point was 
reached after 5 mo exposure. 
The exposed preparations were developed for 5 min 
with Kodak D-19 developer at 20~  Finally, the autora- 
diographs were stained for 10 min with lead acetate (63). 
At the end of the exposure time, the average background 
was 2 grains/1,000 /~m  ~ (range: 1-5 grains/I,000 /zm  2) 
and could accordingly be disregarded. 
Quantitative Evaluation 
of A utoradiographs 
Only autoradiographs obtained from animals treated 
with Su-13 437 were analyzed. The quantitative proce- 
dure was based on the "95% probability" circle method 
of Whur et al. (79). 2 A  circle (resolution-boundary cir- 
cle) 12.4 mm in diameter (corresponding to magnifica- 
tion  level  I  of the  morphometric procedure)  was  en- 
graved on a  transparent plexiglass disk about 7  cm in 
diameter (cf. inset of Fig.  9). On the perimeter of this 
circle, five equidistant points were marked. The autora- 
diographs were then analyzed as follows: The negatives 
(x 2,500) were transformed to positives by contact print- 
ing. These were projected onto a screen by means of a 
table projector unit (final magnification x27,500). The 
transparent disk was randomly superimposed on the pro- 
jector image of the autoradiograph in such a way that the 
engraved  resolution-boundary circle  enclosed  a  silver 
grain. The probability that one or another of the underly- 
ing subcellular compartments (e.g., endoplasmic reticu- 
lum  [ER], mitochondria, PO, etc.) might, through the 
spread of radiation, have contributed radiant energy to 
the developed silver grain was then estimated with the 
aid of the five marks engraved on the circumference of 
the probability circle. If, for example, two of the marks 
"hit" the RER compartment and the other three a PO, 
the chance that the RER and/or the peroxisomal profile 
might have been the source of radiation that generated 
this particular silver grain was estimated to be 2 in 5 or 3 
in 5, as the case may be (cf. inset of Fig. 9). A subceUular 
compartment comprising the whole probability circle was 
therefore rated as  5/5.  The calculations for estimating 
the label distribution will be given below. The autoradi- 
ographic  analysis  was  based  on  about  24,000  silver 
grains.  When  the  labeling was  most dense  (6  h),  the 
average grain density of the autoradiographs was esti- 
mated to be 42/82  p.m  2 (cf. Fig. 8), as compared to 8 
grains in the case of lowest grain density (10 days). 
2 For criticism of the "95% probability" circle concept, 
consult Salpeter and McHenry (66). 
Morphometry 
OENERAL  COMMENTS:  The  preparations  sub- 
jected to morphometric analysis were identical to those 
used for autoradiographic assessments. The specimens 
were  collected  essentially  according  to  Weibel  et  al. 
(78). Three rats treated with Su-13 437 and three con- 
trois given CMC only were examined at each of the ap- 
pointed times. Altogether, 36 rats were used. 
PRIMARY  SAMPLE:  This  consisted  of  about  20 
tissue blocks (-1  mm  a) collected from three different 
regions of the liver. 
SECONDARY  SAMPLE:  From  the  pool  of  tissue 
blocks, five were randomly selected per animal (i.e., a 
total of 30  blocks were  examined on  each  occasion). 
Thin sections were cut from each block (average thick- 
ness -850 A). One section of good quality was chosen 
for the morphometric analysis. Accordingly, altogether 
15 thin sections per group (three animals) were available 
for examination each time. 
TERTIARY  SAMPLE:  From  each  thin section,  six 
random electron micrographs were made on a Siemens 
Elmiskop la at two  magnification levels:  x  2,500  for 
level I and  x  6,000 for level II. The total of 90 micro- 
graphs per group (three animals) and time interval were 
analyzed. The selected tissue areas were photographed 
on  35-mm  film  strips,  which  were  contact-printed on 
film. These positive prints were examined by means of a 
table projector unit yielding an 11-fold secondary magni- 
fication. The final magnifications were thus x  27,500 for 
level I and ￿  66,000 for level If. The magnification was 
calibrated with the help of a carbon grating replica (Er- 
nest F. Fullam, Inc., Schenectady, N.Y.) having 28,800 
lines/in. 
CHOICE  OF  TEST  LATTICES:  For point-counting 
at level I, a rectangular frame (192 x  288 mm) contain- 
ing a double-lattice grid (891 test points, ratio 1:9) was 
used. The level II micrographs were analyzed by means 
of a square frame (240 x  240 mm) which comprised a 
multipurpose test screen (21 test lines, 84 mm of length). 
DESCRIPTION  OF  CELL  COMPARTMENTS:  At 
the magnification level I, point-counting (to determine 
the specific volume of different compartments) and pro- 
file-counting (to determine the specific number of mito- 
chondria,  peribiliary dense  bodies,  lipid droplets,  and 
peroxisomes) were performed. The following cell com- 
partments were considered: extrahepatocytic space, nu- 
cleus,  mitochondria, peroxisomes  (microbodies),  peri- 
biliar dense bodies (including cytolysomes or autophagic 
vacuoles), lipid droplets, RER  (including intercisternal 
and pericisternal areas containing apparently "free" ri- 
bosomes or polyribosomes), and SER (including Golgi 
membranes and glycogen areas). It should be noted that 
the present en bloc definition of the RER was adapted 
for autoradiographic purposes and presupposes that this 
organelle  is  composed  of  an  intracisternal  lumen 
bounded  by  cisternal membranes  with  attached  ribo- 
somes  and  the  intercisternal and  pericisternal ground 
substance, in which generally no structures other than 
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L E V E L  11 :  This higher magnification level allowed 
a more refined point-counting and included RER, SER, 
Golgi apparatus (comprising stacked lamellae and organ- 
elle-associated  secretory  vesicles  containing  very  low 
density lipoprotein particles), compact areas of appar- 
ently "free" ribosomes or polyribosomes, and the cyto- 
plasmic ground substance  (comprising the interparticu- 
late space not already assigned, according to the above 
definitions, to other compartments). 
Although all the compartments listed above were con- 
sidered in  the  morphometric analysis, only those con- 
ceivably related to the biosynthesis of PO will be dealt 
with in this report. 
RECORDING  OF  DATA  AND  COMPUTA- 
TIONS:  The primary counts were processed according 
to criteria already discussed (78) by means of a morpho- 
metric computer program (19). The results were related 
to a liver volume corresponding to 100 g of body weight 
of the animal and thus represent specific dimensions (cf. 
reference 78).  Previous considerations regarding possi- 
ble  sources  of error  in  the  morphometric analysis  of 
tissues (78) also apply to the present work. 
DETERMINATION  OF  SPECIFIC  WEIGHT  OF 
LIVE R  S:  In order to relate the morphometric parame- 
ters to the liver volume, determinations were made of 
the average specific weight of 10 livers each from 10-day- 
old  rats  treated with  either Su-13  437  (mean  specific 
weight: 1.0594 g. ccm  -1) or CMC (mean specific weight: 
1.0632  g. ccm-1). There was no  statistically significant 
difference between the two means. 
ADDITIONAL  RECORDINGS:  At  magnification 
level I, the diameters of peroxisomal profiles were re- 
corded on  a  Zeiss Particle  Size  Analyzer (Cad  Zeiss, 
Oberkochen, Germany). The values obtained were then 
computed into  peroxisomal diameters by  applying the 
Wicksell transformation  (4,  80).  From  level II  micro- 
graphs,  the  ratio  of peroxisomal profiles containing a 
nucleoid (or core) to those lacking such a structure was 
estimated in  thin  sections of the livers of control and 
treated animals. For each group and each experimental 
time-point, 102-293  profiles were recorded. To obtain 
a numerical estimate of the portion of the whole popula- 
tion of peroxisomes made up by the so-called (anucleoid) 
microperoxisomes (cf. reference 49), we took into con- 
sideration a  statistical relationship between the size of 
the nucleoid and  that  of the whole PO,  i.e.,  that  the 
chance of a  nucleoid-containing PO revealing the pres- 
ence of a nucleoid within a given profile is proportional 
to the ratio of the nucleoid diameter to the particle di- 
ameter. For example, a ratio of 0.43 would mean that in 
a  population consisting exclusively of nucleoid-contain- 
ing PO, -43%  of the profiles would have revealed the 
presence of a  nucleoid (cf. Table I). This ratio was de- 
termined for 100 randomly selected PO each in sections 
prepared from livers of control and treated (1.5  days) 
rats. 
Correlation  between Autoradiographic 
and  Morphometric  Data 
It  has already been mentioned that  the counting of 
developed silver grains, their assignment to the different 
subcellular  compartments,  and  the  morphometric  re- 
cording were performed on the same micrographs. To 
begin with, the grain counts of the individual compart- 
ments were expressed per hepatocytic unit volume, i.e., 
number  of grains on  compartment/cm  3 of hepatocyte. 
This  mode  of expression, the  radiation  label  density, 
indicates the relative labeling intensity of the different 
compartments, disregarding their actual contribution to 
the  cell  volume.  A  second characteristic,  the  specific 
radiation  label density, was then calculated.  It reflects 
the grain  counts per unit volume of a  given compart- 
ment,  i.e.,  number  of grains  on  compartment/cm  3 of 
compartment. The rationale of this procedure is as fol- 
lows:  to  estimate  the relative volume  of the compart- 
ments  (i.e.,  volume  density  Vv)  a  lattice  of  random 
points was spread over the sections, and the points failing 
on compartment i, P~, were recorded, yielding the vol- 
ume density of i in the cell being Vw = PdPc, where Pc 
denotes the number of points falling on the hepatocytes. 
To estimate the probable distribution of the label radia- 
tion source, a second lattice of points was used; however, 
these were "grain-associated" rather than random, i.e., 
they were represented by the five points on the circum- 
ference  of the  95%  probability  circle  that  was  fitted 
around the grain (cf. Fig. 9). The number of these points 
falling  onto  a  profile of compartment i,  Gi,  was  also 
recorded.  It  can  be  postulated  that  this  second point 
count is biased by any preferential location of the label in 
one or another of the compartments. The bias due to the 
relative label density in compartment i can be obtained, 
as an initial approximation, from the ratio GdPi, i.e., the 
ratio of grain-associated to random point hits on i. 
To  calculate  the  "true"  label density in  the cell  or 
compartment volume, the section thickness T had to be 
considered. Likewise, the profile area of the cell, Ac, 
over which grains were counted, or of the profile com- 
partment i, A~, had to be expressed in absolute terms; 
because we used a square point lattice of point spacing d, 
these  areas  were  obtained  by Ac  =  Pe'd 2 and A~  = 
P~ .d  2, respectively. The radiation  label density in the cell 
was hence 
Rw  =  Gi/5.Ac. T  =  G~/Pc (5.d 2. T), 
where the  coefficient 5  is related to  the fact that  five 
points were counted for each grain.  The specific label 
density in compartment i  is accordingly 
Rvi  + =  Gi/ P~ (5'd2"T) ￿9 
Hence, it  is readily apparent  that  the formula for the 
specific label density corresponds to 
Rv( + =  Rv~'/Vw', 
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compartment i in the hepatocytes. 
MiIlipore Filtration 
Small aliquots (-0.3 ml) of the resuspended (0.25 M 
sucrose) mitochondria-rich MLP fraction were fixed for 
30 mid at 4~  in  a  4% formaldehyde-l.25%  glutaral- 
dehyde  mixture  and  filtered  through  MiUipore  filters 
(pore size: 0.1 /~m) according to the procedure outlined 
by  Baudhuin  et  al.  (6).  The  pellicles  obtained  were 
washed with cacodylate buffer  (-2  ml) and  their sur- 
faces stabilized  by the addition of a few drops of liquid 
agar.  The filters with adhering pellicles were removed 
from the filtration unit and processed by means of the 
diaminobenzidine (Fluka, Buchs, Switzerland) reaction 
(7) to demonstrate peroxidase activity; control prepara- 
tions  were  incubated  in  a  medium  lacking  hydrogen 
peroxidase, or containing 0.01 M 3-amino-1,2,4-triazole 
(Fluka, Buchs, Switzerland). 
Biochemistry 
AN IM A  LS:  Biochemical  estimations  were  per- 
formed in five to six animals per experimental or control 
group.  The  treatment  schedule  already  described  was 
carefully duplicated, except that no analysis was made 20 
miD after the third dose of Su-13  437. 
TISSUE  FRACTIONATION:  The  weighed  livers 
were homogenized in 0.25 M sucrose with the aid of a 
glass-teflon  homogenizer to obtain  a  5%  homogenate. 
The homogenate was centrifuged at 8,500 g for 30 miD 
(MSE Mistral 6 L), and the resultant pellet was carefully 
rehomogenized in  0.25  M  sucrose.  Debris and  nuclei 
were separated by centrifugation (600  x g for 20 miD), 
and the supernate was spun  at 8,500 g for 30 miD. The 
resultant pellet was washed once under identical condi- 
tions. This fraction was composed of elements of the ER, 
mitochondria,  lysosomes,  and  peroxisomes,  and  is  ac- 
cordingly designated  the  MLP  fraction.  The  8,500  g 
supernate  was  centrifuged  at  105,000  g  for  60  miD 
(Spinco  L2-65B,  rotor  60  Ti),  yielding a  microsomal 
pellet and a supernate (fraction S) containing the soluble 
components of the cytoplasm. 
ENZYME  ASSAYS:  The  activity  of  catalase  was 
estimated in the MLP ("particulate" activity)  and the S 
("free" activity)  fraction,  15  miD after the addition of 
1%  (vol/vol) Triton X-100  (5).  The enzyme assay  fol- 
lowed a procedure described by Creasey (11). The activ- 
ity of the peroxisomal core enzyme urate  oxidase was 
determined according to de Duve et al. (14). 
PROTEIN  DETERMINATION:  The  protein  con- 
tent of the fractions was estimated by the procedure of 
Lowry et al. (45). 
RESULTS 
Proliferative Response 
of Peroxisomes 
DIMENSIONAL  ASPECTS:  In  control  ani- 
mals  the  specific  volume  of  PO  remained  rela- 
tively constant throughout the duration  of the ex- 
periment at a level comparable to that determined 
in  adult  rats  (Fig.  1).  The  same  holds  good  for 
other  peroxisomal  parameters  such  as  the  mean 
volume (Fig. 2), the specific number (Fig. 3), the 
frequency of nucleoid-containing profiles (Fig. 4), 
and the size distribution  (Figs. 5  and 6). Tsukada 
et al. (74) have reported that during a comparable 
postnatal interval several peroxisomal characteris- 
tics did  not  change;  however,  in  contrast  to  our 
findings, they observed a reduction of the particle 
size. 
The  distribution  of  true  diameters  of  PO,  as 
determined  by  the  Wicksell  transformation  of 
measured  particle diameters  (4,  80),  is shown by 
the  stippled  histograms  in  Fig.  5.  It can  be seen 
that the diameters are distributed  around the me- 
dian  values  which  are  clustered  within  a  fairly 
narrow interval, i.e., between 0.39 and 0.43  /xm. 
Although these diameter distributions were based 
on comparably large numbers of particles (-1,000 
per experimental time-point), their contours were 
rather  "notched."  In  fact,  statistical  comparison 
by means of the X  z test of the individual distribu- 
tions in the three animals examined per time inter- 
val  showed  that  the  PO  of  these  three  animals 
could  not  be  regarded  as  belonging to  the same 
sample. The reason for this finding could be either 
that the number of measured particles per animal 
was too small to fill all the size classes evenly, or 
that  the population  representing  the control  ani- 
mals  was  itself  composed  of  different  particle 
types,  which  entered the analysis  with a  variable 
probability.  In fact, recent reports have furnished 
evidence  that  rat  hepatocytes  (and  other  cell 
types)  may contain at least two different kinds of 
PO:  the  so-called  microperoxisomes  (diameter 
-0.20  p.m)  and  the commonly described mature 
variety  (49).  In  addition  to  microperoxisomes, 
peroxisome-like  "Q"  particles  (diameter  -0.25 
/xm) have recently been  reported  to occur in  rat 
hepatocytes  (77).  Although  the  morphogenetic 
and  biogenetic  relationships  between  these  two 
sets  of  structures  remain  to  be  elucidated,  both 
kinds apparently  lack a  matrical core. In the con- 
text of the present experiments, it is important  to 
have a notion of the numerical contribution of the 
microperoxisomes to the whole peroxisomal popu- 
lation. These particles merit particular interest be- 
cause it may be assumed that in rat liver they could 
represent the progenitors of the mature core-con- 
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FIGURE  1  Specific  volume of peroxisomes. Treatment of the animals with Su-13 437 started on the 5th 
postnatal day (denoted by -2 on the abscissa). The rats received five consecutive doses of the drug 
(arrows),  the  last being given on  the  9th  day  postpartum  (day 2).  The  radioactive precursor was 
administered together with the third dose of the drug on the 7th postnatal day which was designated time 
zero (cf. Fig. 10). Accordingly, the whole experiment was divided into two periods. During the first 
interval (which included the sampling times: 20 min, 6 h, and 1.5 days), the animal received the drug until 
day 2 (progression). Medication was then stopped, and the animals were observed during a period of 8 
days (recovery); this second period included the times: 3, 6, and 10 days. The duration of the experiment 
thus covered a postnatal period extending from 7 (day 0) to 17 days (day 10). The level of significance  of 
treated animals, as compared with controls, was P < 0.001 throughout. Standard errors are indicated. The 
value for the untreated adult rat was taken from reference 78. 
taining PO (50) and thus play a decisive role in the 
proliferative response of PO to treatment with Su- 
13 437. According to the statistical considerations 
outlined in  Materials and  Methods,  the  ratio of 
nucleoid to particle diameter was determined for 
100  PO  from  control sections and found to  be 
0.57. Therefore, it could be expected that if the 
counting of nucleoid-containing  PO had been per- 
formed on a particle sample composed exclusively 
of nucleoid-containing  PO, -57%  of the profiles 
would  have  been  rated  as  anucleoid (Table  I). 
As can be seen in Fig. 4, the proportion of anu- 
cleoid peroxisomal profiles in control animals was 
found  to  vary  (insignificantly) between  61  and 
76% (mean: 70%) of the total particle population 
(Table I). Upon comparison of the results (Table 
I)  obtained  from  the  determination of  the  nu- 
cleoid-to-particle size ratio (57 % of an  ucleoid par- 
ticles) and the  counting of core-less PO  profiles 
(70%),  it would appear that  our counts of anu- 
cleoid profiles included only -13% of truly (anu- 
cleoid)  microperoxisomes and/or  "Q"  particles. 
Similar  determinations performed  on  PO  from 
treated (1.5 days) animals revealed that in spite of 
the expansion of the  PO compartment, the pro- 
portion  of  microperoxisomes remained virtually 
unchanged (Table I). From these observations, it 
is concluded that the so-called microperoxisomes 
make up a minor fraction of the total PO volume; 
this part of the PO population is not altered to any 
significant extent during drug-induced PO prolif- 
eration, thus most probably excluding a precursor- 
product  relationship between  microperoxisomes 
and  mature  PO.  As  represented  in  Fig.  4,  the 
proportion of anucleoid PO profiles increases con- 
siderably during drug treatment. By determining 
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FmURE 3  Specific number of peroxisomes. In control animals the value of day 10 is significantly  lower 
(P <  0.01) as compared with 20 min. The level of significance of treated rats, as compared with controls, 
was P  <  0.001 throughout. For treated rats, the values attained on days 3 and 6 were significantly  higher 
(P <  0.001)  in comparison with  1.5  days.  Similarly,  the value of day  10 was significantly  lower (P  < 
0.001) than that determined at the beginning of the experiment (20 min). Standard errors are indicated. 
The value for the untreated adult animal was taken from reference 78. 
the  apparent  diameter  of  the  nucleoids  in  100 
randomly selected PO profiles in each of the con- 
trol  and  treated  groups,  it  was  shown  that  the 
mean  apparent  diameter  of the  nucleoid  (-0.18 
/tm)  was  not  significantly changed  as  a  result  of 
the  administration  of  the  drug.  Therefore,  the 
increase  in  the  frequency  of  anucleoid  particles 
(Fig. 4) was not due to a  reduction  in the size of 
the  core material attributable  to the influence of 
Su-13  437.  Consequently,  the  ratio  of  the  nu- 
cleoid diameter to the particle diameter suffered a 
roughly twofold decrease  (from  0.43  to  0.27)  in 
the presence of the drug. 
Treatment  of  5-day-old  rats  with  Su-13  437 
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FIGURE 4  Frequency of anucleoid (core-less)  peroxi- 
somal  profiles  in percent of total peroxisomal  profiles. 
The upper parts of the columns marked A represent the 
anucleoid portion of the total peroxisomal profiles. The 
data are based on 725 and 1,476 profiles for control and 
treated animals, respectively.  Standard errors are indi- 
cated. 
caused  a  marked  expansion  of  the  peroxisomal 
compartment. There  was  a  dose-related increase 
in the  specific volume of PO  in the  hepatocytic 
cytoplasm, which reached its maximum on the 3rd 
day, i.e., one day after the administration of the 
last dose (Fig.  1). Similarly, the mean volume of 
PO was increased, with a peak on day 1.5 (Fig. 2). 
The  number  of  PO  was  also  augmented  and 
reached a  plateau between day 3  and day 6  (Fig. 
3). The distribution of PO diameters as obtained 
from  the  Wicksell transformation clearly showed 
that the administration of Su-13 437 to neonatal 
rats caused an increase in the particle diameters, 
resulting in a considerable shift in the distribution 
toward  higher  values  (Fig.  5).  After  treatment 
with  four  doses,  the  mean  particle  diameter  in- 
creased  from  -0.4  to  -0.6  /Lm.  Consequently, 
the  average  PO  of treated  animals was enlarged 
by a factor of -3.5 (Fig. 2). From the distribution 
of diameters represented in Fig. 5, it can be seen 
that  during  the  drug-induced  expansion  of  the 
peroxisomal  compartment,  e.g.,  at  6  h  and  1.5 
days, fewer of the smaller particles falling within 
the  distribution characteristic  of the  control  ani- 
mals were present in the treated rats. This numeri- 
cal deficit in particle sizes belonging to the control 
distribution is clearly evident if an attempt is made 
to  evaluate  it  graphically.  In  Fig.  6,  the  drug- 
induced distribution of peroxisomal profile diame- 
ters is represented. If it is assumed that this distri- 
bution is a  composite one comprising particles of 
control and drug-induced sizes, the proportion of 
the latter can be estimated by subtracting, in each 
diameter class, the control value from the counts 
obtained from treated animals. The resultant his- 
tograms (Fig. 6) might thus reflect the size varia- 
tions of PO due to the drug treatment. From Fig. 
6,  the  following conclusions may be  drawn:  the 
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FIGURE 5  Distribution of true peroxisomal  diameters 
as obtained by Wicksell transformation. The values refer 
to identical tissue areas used for determination of profile 
diameters. The stippled  areas represent the distribution 
of peroxisomes  in the controls, whereas  the solid lines 
indicate  the  distribution pattern  in  treated  rats.  The 
mean diameters of peroxisomes  of control and treated 
animals were denoted by )(c and XT, respectively. 
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FIGURE 6  A graphic attempt to demonstrate the possi- 
bility that a new category of peroxisomes would emerge 
during drug treatment. For each class of profile diame- 
ters, the control value was subtracted from the corre- 
sponding value  for  drug-treated  animals (  ).  The 
resultant distribution (--)  is indicative of the appear- 
ance of a  drug-induced particle  population of a larger 
size range (shaded areas). The negative values obtained 
at 6 h and 1.5 days could be interpreted in terms of a 
relative deficiency  of smaller peroxisomes  in the  size 
range present in normal hepatocytes, During the recov- 
ery period, e.g., on days 3 and 6, the number of larger 
organelles was  gradually reduced  (cf.  Fig.  5)  with  a 
concomitant resurgence  of  the  population of  smaller 
particles.  The data refer to equal areas of liver tissue. 
TABLE  1 
Estimation of the Number of "'True" Anucleoid 
Peroxisomes (Microperoxisomes) 
Number of anucleoid particles in percent 
of total peroxisomes 
Based on  Based on  Difference 
diameter  counts of nu-  =  "true" 
ratio nu-  cleoid-con-  anucleoid 
deoid/per-  taining pro-  peroxi- 
Treatment  oxisome  files  somes 
Control  57  70  13 
Su-13  437  (1.5  73  88  15 
days) 
proliferative response of PO to the drug is coupled 
with  a  relative  impoverishment  of  particles  be- 
longing to the control size distribution. This deficit 
was greatest after  1.5 days, when the mean parti- 
cle  volume had  attained its peak  value (Fig.  2). 
Upon withdrawal of Su-13 437, the size range of 
control particles was progressively refilled. 
It is  noteworthy that  under the  stimulation of 
Su-13 437, the different peroxisomal parameters 
all  reflected  the  expansion  of  the  PO  compart- 
ment. However, in comparing the times of occur- 
rence of their respective peak values, some differ- 
ences  were  observed.  For  example,  the  specific 
volume of PO was at its maximum on the 3rd day, 
i.e.,  1  day  after  drug  therapy  was  discontinued 
(Fig.  1).  The  highest value of the  mean particle 
volume,  however,  was  reached  about  1.5  days 
earlier (Fig. 2). From this, it might be concluded 
that  the  increment  in  specific  volume  observed 
between days  1.5  and 3  (Fig.  1)  does not result 
from a further increase in the particle volume, but 
may  be  mainly  caused  by  the  reappearance  of 
smaller particles which apparently belong to  the 
size range of the control animals (Fig. 6). In this 
context, it should be noted that the specific num- 
ber of PO reached  its maximum on day  16  (Fig. 
3), most probably through the joint contribution 
of  remaining  larger  PO  and  newly  recruited 
smaller ones (Figs. 5  and 6). These relationships 
are represented in Fig. 7. 
BIOSYNTHETIC  ASPECTS:  Figs.  8  and  9 
represent  the  general  aspect  of  the  autoradi- 
ographs used for the present analysis at two differ- 
ent  magnification and labeling levels.  Fig.  8  de- 
picts the  situation encountered when the  density 
of developed silver grains were greatest (42 grains/ 
82  /zm2),  i.e.,  6  h  after  administration  of 
[3H]arginine. In the course of the experiment, the 
extent of labeling was reduced as a  result of pro- 
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6  10 
tein turnover. Fig.  9  represents an intermediate 
stage, i.e., 3 days after the injection of the isotope, 
when the  average grain density amounted to  28 
grains/82 ~m  2. 
Throughout  the  experiment  the  ER  was  the 
most extensively labeled compartment of the liver 
parenchymal cell (Table II). In general, the grain 
density was higher over the  RER than over the 
SER (Table II and Fig.  10); this difference was 
more  pronounced during the  early  postlabeling 
stages (Fig. 10). Examination of the specific label 
density, however, revealed no essential difference 
in the total grain content between the RER and 
SER (Fig. 11). It is thus concluded that the silver- 
grain concentration over the  RER and SER was 
comparable. 
As can be seen from Figs. 10 and 11, the time- 
course  of  radiation  label  density  (Fig.  10)  and 
specific  label density (Fig.  11) of the  ER  mem- 
branes did not follow a  more or less exponential 
curve, as would have been expected if the isotope 
initially present had been "chased" from the ER 
by incoming nonradioactive molecules, as a conse- 
quence of membrane replacement. Instead, a pla- 
teau occurred between days 1.5 and 3. The signifi- 
cance of this observation is not clearly understood, 
but it should be remembered that the drug treat- 
ment was  discontinued between these two time- 
points (cf. Fig. 1). In addition, we have observed 
that  Su-13  437  behaves  like  a  liver-inducing 
agent,  a Therefore, in common with some of these 
agents,  such  as  phenobarbital, it  may  have  the 
capacity to influence protein metabolism (cf.  ref- 
erences  15,  18,  28,  33,  36,  and 64).  It is  thus 
conceivable that,  upon  withdrawal of the  drug, 
important  metabolic  changes  might  have  inter- 
vened which could in turn have entailed shifts in 
metabolic pool sizes.  Such alterations might also 
have  markedly influenced the  metabolic fate  of 
the reusable isotope. Furthermore, the disposal of 
PO  containing  radioactive  proteins  which  oc- 
curred  during the  recovery period  may perhaps 
have contributed a sizable amount of labeled low- 
molecular products to the metabolic pools. 
Although the Golgi apparatus collected a rather 
limited amount of silver grains (Table II and Fig. 
12), its specific label density at 6 h was among the 
highest  observed  in  all  compartments  analyzed 
(Fig. 13). 
As previously shown, the dense-body compart- 
ment which was defined as including autophagic 
vacuoles (or cytolysosomes) accounts for a minor 
volume fraction  (0.0106-0.0322  ml/100 g  body 
weight) in the livers of both control and treated 
animals; in addition, this parameter was not signif- 
icantly changed as  a  consequence of drug treat- 
ment.  4 Accordingly, the  radiation  label  density 
exhibited by these organelles was small through- 
out the duration of the experiment (Table II, Fig. 
12).  Different results were  obtained by plotting 
the specific label density (Fig. 13). In this case, at 
the earliest postlabeling time (20 rain), the values 
were in the same range as those of the ER (Fig. 
11). At 6 h, however, a peak was observed which 
was  the  highest  observed  in  all  compartments 
studied,  although  it  did  not  significantly differ 
from the corresponding value for PO. The values 
then declined sharply until day 3; from then on, 
the concentration of silver grains over the dense 
bodies diminished more slowly, possibly because 
labeled PO, as well as other cytoplasmic compo- 
nents destined for breakdown, had  entered  this 
compartment in the form of cytolysosomes. 
3 W. Stiiubli, W. Schweizer, and J. Suter, unpublished 
results.  It  was found  that  oral  administration of five 
doses of Su-13 437 (100 mg/kg) to 5-day-old  rats caused 
a (reversible) doubling of the specific surface of hepato- 
cytic SER membranes to  ~30 m2/100 g body weight. 
Similarly, the specific activity of the microsomal amino- 
pyrine N-demethylase was increased from 0.0077  /xg 
formaldehyde formed/mg protein/s (control) to 0.0107 
/zg/mg protein/s (five doses of Su-13 437). 
4 W. Stiiubli and J. Suter, unpublished observations. 
674  THE  JOURNAL OF  CELL BIOLOGY' VOLUME 74,  1977 Fmuvm  8  Low-power  autoradiograph  obtained  6  h  after  administration  of  [SH]arginine.  Note  the 
presence of silver grains over nuclei (N), mitochondria (M), peroxisomes (arrowheads), rough (RER) and 
smooth (SER) endoplasmic reticulum, Golgi region (GO), and lipid droplets (arrows). Scale bar, 1/zm. x 
6,250. 
ST,~UBLI, SCHWEIZER, SUTER, AND  WEIBEL  Effects of SU-13 437 on Hepatocytes  675 FmURE  9  Autoradiograph representing parts of two adjacent hepatocytes 3 days after the injection of 
[aH]arginine. About 10% of the total silver grains could be attributed to the peroxisomes (arrows). Scale 
bar,  1 /zm.  ￿  12,500.  Inset:  Positioning of the resolution-boundary circle (diameter: 12.4  mm) over a 
developed silver  grain.  By means of the five  equidistant points, the contribution of the different cell 
compartments to a given silver grain was estimated as exemplified under Materials and Methods. Scale bar, 
1 /zm.  x  27,500. 
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Distribution of  Radiation Label Density in Cell (RV') between the Main Cellular Compartments of  the Hepatocyte 
Time after [3H]arginine in- 
jection  RER  SER  Mitochondria  Nuclei  Peroxisomes  Golgi  Dense  bodies 
%  %  %  %  %  %  % 
20 min  39.4  24.5  22.4  7.5  4.2  1,6  0.4 
6 h  33.0  23.5  22.7  11.9  6.7  1.8  0.4 
1.5 days  33.4  23.2  23.6  7.5  10.1  1.4  0.8 
3 days  31.5  20.5  30.0  6.9  10.0  0.7  0.4 
6 days  27.3  21.7  30.7  12.9  5.4  1.2  0.8 
10 days  31.7  25.9  29.2  7.8  2.4  2.2  0.8 
It was interesting to note that the radiation label 
density of PO was the only parameter studied in 
the present investigation which displayed a plateau 
between 6  h  and 3  days; after the withdrawal of 
the drug, the radiation label density of the peroxi- 
somal compartment declined (Table II; Fig.  12). 
20  min  after  administration of  the  isotope,  the 
specific  radiation  label  density  was  of  the  same 
magnitude (Fig. 13) as that of the ER (cf. Fig. 11). 
At 6  h, this parameter attained a  peak in PO, in 
contrast to the ER; at 1.5 and 3 days, the specific 
label density of PO was still higher than at the be- 
ginning of the experiment; thereafter, i.e., during 
the  recovery  period,  the  label  density  per  unit 
volume of PO gradually diminished (Fig.  13). 
To establish a  relationship between the size of 
the PO and their label density, we determined the 
dimensions of labeled and unlabeled peroxisomal 
profiles by means of the particle size analyzer (Fig. 
14).  It can be  seen that  the  majority of labeled 
peroxisomal profiles were found in the larger di- 
ameter  classes  and,  thus,  followed  closely  the 
drug-dependent size increase of the particles. This 
observation  suggests  that  the  isotope,  once  in- 
corporated into a PO of an expanding population, 
remained associated  with  the  particle  during its 
enlargement in the course of drug treatment. This 
finding is more explicitly described in Table III, 
which indicates the grain distribution over peroxi- 
somal profiles  of two  different size  classes.  It  is 
obvious that the ratio of labeled to unlabeled pro- 
files is generally much lower in the small class than 
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density  of  ER  membranes  in  cell  (RV).  The  labeled  amino  acid, 
[aH]arginine, was administered together with the third dose of the drug, i.e., on day 0 (arrowhead). The 
liver tissue was removed 20 min, 6 h, 1.5, 3, 6, and 10 days after the isotope injection and processed for 
morphometry and autoradiography. For further experimental details, see Fig.  1. For all parameters, the 
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days. The differences  between all other values are significant.  Standard errors are indicated. 
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20 rain vs. 6 h, 20 min vs. 1.5 days, 20 rain vs. 10 days, 1.5 vs. 3 days, 1.5 vs. 10 days, 3 vs. 10 days, 6 vs. 
10 days. All other differences are significant. Standard errors are indicated. 
in  the  large  class,  suggesting  a  preferential  in- 
corporation  of  the  isotope  into  the  larger-sized 
organelles.  With  the  continuation  of  treatment, 
i.e., between 6 h and 3 days, the ratio of labeled to 
unlabeled small profiles progressively diminished. 
In  contrast,  the  extent  of  labeling  of  the  larger 
particles  remained  constant,  and  only  declined 
when the drug was withdrawn.  Closer inspection 
of Fig.  14 reveals that the smallest labeled peroxi- 
somal  profiles  were  somewhat  larger  than  the 
smallest  unlabeled  profiles.  As  the  experiment 
proceeded, the size of the smallest labeled particle 
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Standard errors are indicated. 
profile gradually shifted to higher diameter classes 
(cf.  arrowheads on the abscissa of Fig. 14), indi- 
cating that  the  isotope  distribution reflected the 
drug-induced size  changes  occurring within  the 
peroxisomal population. 
Biochemical Findings 
In untreated animals, the activity of some of the 
peroxisomal enzymes tended to increase moder- 
ately toward the end of the experiment (Tables IV 
and V), in accordance with the postnatal activity 
pattern established for rat liver (74). 
It  was  anticipated from  the  uniform staining 
behavior of the expanding peroxisomal population 
after peroxidase cytochemistry (results not shown) 
that the biochemically determined catalase activity 
of hepatic  mitochondrial fractions isolated from 
drug-treated animals would be enhanced. In fact, 
as shown in Table IV, the specific activity of this 
enzyme in the MLP fractions obtained from rats 
that  had  received  five  doses  of  Su-13  437  was 
lower than that of the corresponding control frac- 
tions. In contrast, the soluble fraction of livers of 
treated animals displayed a considerable catalase 
activity,  which  reached  a  peak  at  the  stage  of 
greatest  expansion of the  peroxisomal compart- 
ment (Fig. 1). During recovery from medication, 
this enzyme activity tended to  return to  control 
levels (Table IV). The most obvious explanation 
for this drug-related shift in the subcellular distri- 
bution of catalase activity is that this enzyme was 
in part leached-out from the PO of treated animals. 
This interpretation was supported to some extent 
by observations made on Millipore-filtered MLP 
fractions (Fig.  15). If such fractions were treated 
according  to  the  DAB  procedure  in  order  to 
reveal  peroxidase  activity,  most  of  the  reactive 
particles showed  an  inhomogeneous distribution 
of the reaction product within their matrix. The 
appearance of variable proportions of the matrical 
space  completely  devoid  of  histochemical  stain 
suggested  that  a  loss  of  DAB-reactive material 
from most of cell-free PO had probably occurred 
during preparation of the  cell fractions. Appar- 
ently, part of the leached-out peroxisomal catalase 
appeared  in  the  soluble  fraction;  however,  the 
sum of enzyme activities recovered in the  MLP 
and soluble fractions of treated  animals did  not 
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FIGURE 14  Distribution of silver grains over peroxi- 
somal profiles of various size classes after the administra- 
tion of [aH]arginine.  A profile was registered as labeled 
if more than half of the area covered by a grain was 
located within the perimeter of the profile. The arrow- 
heads point to the smallest labeled profiles. For compari- 
son,  the  size distribution  of  control  peroxisomes is 
shown. 
much exceed those of the control fractions (Table 
IV), as would have been expected from roughly 
a sixfold  increase of peroxisomal specific volume 
(Fig. 1). There are several possible explanations to 
account for  this  obvious discrepancy.  (a)  It  has 
been shown in liver homogenate of CPIB- or na- 
fenopin-treated rats that the increase in the activ- 
ity or content of catalase was regularly less promi- 
nent than the proliferative response of the peroxi- 
somal compartment (26,  57,  61).  (b)  In treated 
animals, a relatively greater proportion of catalase 
might cosediment with microsomal structures (76) 
which were not analyzed in the present study. (c) 
Part  of  the  "solubilized"  peroxisomal  catalase 
could have been adsorbed on microsomal mem- 
branes. 
Treatment of infant rats with five doses of Su-13 
437 moderately depressed the specific  activity of 
the core enzyme urate oxidase (Table V). 
Recovery Period 
Upon cessation of drug treatment, all the PO- 
related parameters declined, thus demonstrating 
the reversibility of the proliferation process. This 
applied to  the  specific  volume (Fig.  1)  and the 
mean volume (Fig.  2)  as  well as  to  the  specific 
number (Fig.  3).  The contraction of the  peroxi- 
somal  compartment during the  recovery  period 
proceeded gradually. As can be seen in Figs. 5 and 
6, the number of drug-induced larger particles was 
continuously reduced. Concomitantly, the PO of 
smaller size  classes,  which  were  numerically re- 
duced during drug treatment, were gradually re- 
filled (Fig. 6). As a result of these two processes, 
the  overall size  distributions of PO  finally reap- 
proached the control shape (Fig. 5). 
It follows from the foregoing considerations that 
the disposal of the excess  PO formed in the pres- 
ence of Su-13 437 is an important aspect of the 
recovery period. In general agreement with obser- 
vations of Svoboda and Reddy (72), our evidence 
indicates  that  two  different  destruction  mecha- 
nisms might be operative in the hepatocytes. The 
first  process is considered to be of an autophagic 
nature, whereas  the  second can be  described as 
consisting  of  a  "dissolution"  of  individual PO 
within the cytoplasmic matrix, apparently without 
the  involvement of  segregating  membranes (cf. 
reference 70). 
The  liver-inducing capacity  of  nafenopin has 
already  been  documented  (cf.  footnote  3).  It 
could be argued that the disposal of the excess  of 
SER  membranes and  PO  during the  regression 
phase would necessarily have called for an activa- 
tion  of  the  lysosomal system.  As  demonstrated 
earlier, neither the volume density nor the numer- 
ical  density of  these  organelles was  remarkably 
increased during the recovery period (cf. footnote 
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Ratio of Labeled to Unlabeled "Small" and "Large" Peroxisomal Profiles* 
Number of labeled  peroxi-  Number of unlabeled  peroxisomal 
somaLI profiles  profiles  Ratio of labeled  to unlabeled  profiles 
Time after [SH]arginine 
injection  Small  Large  Small  Large  Small  Large 
20 min  29  365  1,012  3,082  1:35  1:8.4 
6 h  77  654  1,220  2,384  1:16  1:3.7 
1.5 days  41  596  1,337  2,539  1:33  1:4.3 
3 days  24  727  2,117  3,245  1:88  1:4.5 
6 days  4  67  1,693  1,755  1:423  1 "26.2 
* The limit between "small" and "large" peroxisomal profiles was arbitrarily set at a diameter of 0.3833  /zm. The 
small diameter class would comprise the bulk of particles whose diameters fall within the size distribution of control 
peroxisomes (cf. Fig. 5). 
TABLE IV 
Subcellular Distribution of Hepatic Catalase Activity 
Catalasr activity 
Experimental time- 
Subcellular  fraction  point  Control  Treated  P* 
t~nol/mg protein/s 
Mitochondria  (MLP  6 h  29.07_+5.76*  13.59_+2.08 
fraction)  1.5  days  18.51_+4.14  10.36_+3.48 
3 days  26.75_+6.88  18.61 _+2.74 
6 days  22.24_+2.28  32.73_+3.91 
10 days  42.57_+3.63  49.29_+4.16 
Postmicrosomal  su-  6 h  0.99---0.64  (616)w  7.76---0.57 
pernate  (S  frac-  1.5  days  0.29  (1/5)  9.76---0.22 
tion)  3 days  0.21  (2/6)  10.80_+0.50 
6 days  0.27  (4/6)  6.36_+0.84 
10 days  0.02  (1/6)  0.64 
Fraction MLP +  S  6 h  30.06  21.26 
1.5 days  18.80  20.12 
3 days  26.96  29.41 
6 days  22.51  39.09 
10 days  42.75  49.93 
(6/6) 
(5/5) 
(6/6) 
(6/6) 
(4/6) 
<0.001 
>0.05 
>0.05 
<0.001 
<0.05 
<0.001 
<0.001 
<0.001 
* Level of significance. 
r  Standard deviation. 
w Numerical ratio of animals showing a detectable enzyme activity to total number of animals. 
TABLE  V 
Urate Oxidase Activity of  the Mitochondrial Fraction 
(MLP Fraction) 
Urate oxidase  activity 
Experimental 
time-point  Control  Treated  P* 
nmol/mg proteinlh 
6 h  228.2-+50.0r  165.1-+113.4  >0.05 
1.5 days  325.9-+135.5  284.9-+125.7  >0.05 
3 days  521.4-+228.6  300.4_+71.9  <0.05 
6 days  262.9-+99.9  201.5-+130.4  >0.05 
10 days  348.5-+108.4  240.1--.50.5  >0.05 
* Level of signiticanee. 
:[: Standard  deviation. 
4).  Similarly,  the  specific label  density  of dense 
bodies displayed no important changes during the 
restitution  phase  (Fig.  13),  indicating  that  this 
compartment  did not receive a  sizable portion of 
radioactive  material  from  those  structures,  i.e., 
SER  and  PO,  which,  by  virtue  of  their  drug- 
induced proliferation, would have suffered a  par- 
ticularly extensive breakdown. 
DISCUSSION 
General Considerations 
In evaluating the results presented in this paper, 
ST,~UBLI,  SCHWEIZER,  SUTER, AND  WEIBEL  Effects of SU-13 437 on Hepatocytes  681 FIGURE 15  The DAB procedure for peroxidase  as applied to Millipore pellicles obtained from  MLP 
fractions reveals that the great majority of peroxisomes contain  only residual patches of electron-dense 
deposits (particles labeled PO 1 and PO 2) or possibly no reaction product at all (structure labeled PO 3, 
which admittedly could also represent a damaged  mitochondrion).  The arrow indicates one of the rare 
peroxisomal profiles completely filled with reaction  product  and thus resembling the organelles usually 
encountered  in DAB-reacted tissue sections. Scale bar, 1 p.m. ￿  27,000. 
it is important to bear in mind the particular condi- 
tions  under  which  the  experiments were  carried 
out.  Because  liver  tissue  of  postnatal  rats  was 
used, it was to be expected that during the experi- 
mental period (7th  to  17th  day postpartum)  the 
metabolism of liver parenchymal cells would be 
subject to a series of complex developmental alter- 
ations (21, 34, 43), thus precluding the establish- 
ment of steady-state conditions in the tissue as a 
whole.  Nevertheless, however marked the diver- 
sity in the developmental kinetics of some impor- 
tant morphological and biochemical parameters of 
the maturing hepatocyte may be, the specific vol- 
ume and number of mitochondria (results not pre- 
sented) and of peroxisomes (Figs. 1 and 3) tended 
to be stable throughout the period of observation. 
It seems reasonable to assume that the adminis- 
tration of the hypolipidemic drug Su-13 437  (na- 
fenopin) to newborn rats might profoundly influ- 
ence  the  metabolic  dynamics  of  the  hepatocyte 
differentiation process. In this respect, it should be 
mentioned that this drug, in addition to being an 
excellent  peroxisome-proliferating  agent,  also 
caused  liver  induction  and  an  elevation  of  the 
specific volume and number of mitochondria (data 
not shown). 
Autoradiographic  Observations 
If the time-course of the radiation label density 
(Fig. 10) and the specific label density (Fig. 11) of 
the different ER membranes is followed, it can be 
seen  that  these  parameters were  highest  20  min 
after  the  injection  of the  isotope,  and  declined 
from then on.  In contrast to the labeling pattern 
displayed by the  ER  membranes,  the  grain con- 
centration over the  Golgi complex was lower 20 
min  after the  administration of the  isotope than 
after 6 h (Figs. 12 and 13), indicating that at least 
part of the labeled material had shifted from the 
ER to the Golgi membranes during this time inter- 
val. This distribution of labeled material is entirely 
compatible with the  well-established observation 
that many proteins synthesized by the hepatocyte 
for extracellular destinations display an  ordered 
migration  within  sequentially arranged  cytoplas- 
mic membrane systems (17, 32, 48, 53). 
It was interesting to note that the dense bodies 
exhibited the  highest specific label density of all 
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tion of silver grains over these particles is appar- 
ently not due to a drug-induced increase in lysoso- 
mal activity, because in hepatocytes of untreated 
animals  the  lysosomes also  showed a  high grain 
concentration (1), in accordance with recent bio- 
chemical findings indicating a high turnover rate of 
lysosomal proteins (75). 
The majority of the autoradiographic parame- 
ters  had  reached  a  minimum  6  days  after  the 
injection of [3H]arginine, except in the Golgi ap- 
paratus.  Between  the  6th  and  10th  postlabeling 
day, the  specific label  density of this  membrane 
system  was considerably  increased  (Fig.  13).  In 
unpublished experiments,  we have observed that 
the number of Golgi-associated secretion vacuoles 
containing lipoprotein particles was reversibly re- 
duced during drug treatment.  It is thus conceiv- 
able that the increase in the silver-grain concentra- 
tion  over  Golgi  elements  on  day  10  (Fig.  13) 
reflects the restoration of their activity. It should 
be mentioned that  the very low density lipopro- 
teins of human and rabbit serum contain an argi- 
nine-rich apoprotein  species (67,  68) which may 
preferentially  carry  the  label  found  over  Golgi- 
associated structures in the autoradiographs. 
Proliferative Response 
of Peroxisomes 
It is well established that the treatment of adult 
rodents with the lipid-lowering agents CPIB (ciofi- 
brate),  Su-13  437  (nafenopin),  or  Sail-42  348 
results in a proliferative response of PO (20, 30, 
39, 42, 47, 56, 70). Recent evidence points to the 
possibility that this expansion of the peroxisomal 
compartment  is  causally  linked  to  the  hypolipi- 
demic action of these agents (39, 58). The present 
study demonstrates that the drug Su-13 437 also 
leads to an activation of the peroxisomal compart- 
ment of neonatal rats,  manifested in a large (ap- 
proximately  sixfold)  increase  in  the  specific vol- 
ume (Fig. 1) and a moderate (approximately two- 
fold)  rise  in  the  specific  number  (Fig.  3).  The 
expanding state  of PO was also reflected  by the 
autoradiographic data. For example, the radiation 
label density, as expressed in percent of total grain 
counts,  increased  in  a  roughly  dose-dependent 
manner up to the  3rd day, whereas in the other 
compartments the same parameter remained sta- 
ble or declined.  On the 3rd postlabeling day, the 
PO occupied -6%  of the hepatocytic cytoplasm 
and had assembled -10 % of the total silver grains 
(Table II). These findings suggest that the prolifer- 
ating PO incorporated a  considerable  amount of 
the isotope, in accordance with biochemical obser- 
vations which indicate a high incorporation activ- 
ity of expanding PO (42). 
As a  consequence of the  discrepancy between 
the numerical increase and the volumetric increase 
of expanding PO mentioned above, a part of them 
responded  to  the  presence  of  the  drug  with  a 
gradual enlargement (Figs. 2, 5, and 6), resulting 
in a  relatively broad and  flat size distribution  of 
the  whole  particle  population,  which  extended 
from -0.2 to -1.0/zm in diameter (Fig. 5). It is 
noteworthy that the expanding particle population 
still included, though in a smaller relative number, 
PO of the size range encountered in control ani- 
mals (Fig.  5).  This observation suggests that the 
whole  expanding  PO  population  may  be  com- 
posed of at least two subpopulations. One of these 
is thought to consist of particles showing the con- 
trol pattern of size distribution and the tendency to 
diminish  in  number  during  drug  treatment.  The 
other subpopulation would be constituted by PO 
responding to the drug stimulus with proliferation 
and enlargement.  However, we did not succeed, 
by graphical means, in demonstrating unambigu- 
ously that the overall drug-induced size pattern of 
treated  rats  was  the  result  of  two  overlapping 
distributions  made  up  of  "control"  and  "drug- 
induced"  particles,  respectively.  This failure  was 
probably related to the fact that either our treat- 
ment schedule did not establish steady-state condi- 
tions  under  which  a  maximal  separation  of the 
subpopulation  would possibly  have  occurred,  or 
the particle counts were suboptimal. Nevertheless, 
when the particle population of control livers was 
subtracted  from the experimental  distribution,  it 
became obvious that the latter was somewhat defi- 
cient in smaller PO (Fig. 6), in spite of an increase 
in the total number of PO (Fig. 3). 
In fact, a large body of evidence lends support 
to our hypothesis that the PO formed under medi- 
cation with aryloxyisobutyric acid derivatives dis- 
play a  particular  behavior,  and  thus  represent  a 
class of peroxisomes unique in various respects. (a) 
There is an increased frequency of anucleoid PO 
profiles (Fig. 4) which apparently is not related to 
an  augmentation  of  the  so-called  microperoxi- 
somes  (Table  I),  but  instead  reflects  an  altered 
balance between nucleoids and matrical constitu- 
ents in the enlarged PO (Figs. 2 and 5).  (b) The 
subceUular distribution of hepatic catalase activity 
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lost from the peroxisome-rich mitochondrial frac- 
tion and displaced to the postmitochondrial super- 
nate (Table IV). This finding is in accordance with 
recently published work in which the various as- 
pects  of the  distributional effects  of  Su-13  437 
(42)  and  Sail-42  348  (47)  on  peroxisomal en- 
zymes have  been  comprehensively discussed.  A 
similar compartmental  redistribution of catalase 
activity was also encountered in the livers of CPIB- 
treated rats and interpreted in terms of a preferen- 
tial leaching-out of catalase from PO (25, 26, 35, 
42, 47), eventually leading to particles which, in a 
cell-free state, contain a reduced catalase comple- 
ment (Fig. 15).  In fact, it has been reported that 
this enzyme is a  most readily solubilized compo- 
nent of PO (22, 46) and may be used as a marker 
of the physical integrity of these organelles (22). 
In addition, we have observed that hepatic PO iso- 
lated from livers of CPIB-treated rats tended to 
reach a  lower density than  those from  untreated 
animals  during  centrifugation  in  Ficoll  density 
gradients  (25);  in  a  recent  study,  it  was  shown 
that  CPIB  treatment caused the emergence of a 
less dense  rat liver PO  class (23).  Furthermore, 
it has been pointed out that during drug-induced 
expansion of PO, the numerical increase in peroxi- 
somal particles largely exceeded the increase (ap- 
proximately twofold) in  liver catalase activity or 
concentration, suggesting the occurrence of rela- 
tively catalase-deficient PO  (57,  61).  This inter- 
pretation is supported by observations indicating 
that  during  treatment  with  CPIB  (40)  of Su-13 
437  (42) a  part of hepatic PO stained less inten- 
sively with the DAB procedure than did PO of un- 
treated  animals.  (c)  A  considerably altered en- 
zyme  pattern  is  exhibited  by  aryloxyisobutyric 
acid-induced PO (3, 20, 26, 39, 42, 47, 71). (d) 
The  labeling behavior  of  PO  during  their  pro- 
liferative phase did not fit a  Poisson distribution 
(Table VI), indicating that only a  certain part of 
the  whole  particle  population  had  incorporated 
the isotope. In contrast, the grain distribution over 
mitochondria, in  accordance  with  other findings 
(9), tended to satisfy the requirements of a  Pois- 
son  distribution (Table VI), as would have been 
expected for the labeling of a metabolically homo- 
geneous  population.  (e)  Drug-induced  PO  were 
observed to display distinctive morphologic char- 
acteristics, such as a more pronounced variation in 
size and shape (20, 41, 42, 57, 59, 73), eccentri- 
cally located nucleoids (51),  an  altered electron 
density of the matrix (41, 42), or the occurrence 
of special matricai structures (29, 57). 
Biosynthesis  of Peroxisomes 
Shortly  after  the  injection  of  a  radioactive 
amino acid (20 min), the specific label density of 
PO was found to be in the region of that recorded 
for the  ER  membranes  (Figs.  11  and  13).  This 
finding might suggest that both compartments are 
equally well supplied with the isotope; but it does 
not, of course, prove the widely accepted notion 
that the PO represent locally differentiated zones 
of the ER  (cf. references 7,  29,  47, 60).  As the 
grain  concentration  over the  ER  was  declining, 
presumably as a  result of a  migrational efflux of 
proteins, the specific label density of PO reached 
its peak 6 h after isotope administration (Fig. 13). 
Thus,  between  20  min  and 6  h  the PO received 
additional amounts of radioactive material, most 
probably at the expense of the ER radioactivity. 
These  observations suggest  a  different temporal 
labeling behavior of the ER and PO, compatible 
with the timing of catalase biosynthesis (38). For 
several obvious reasons, autoradiographic analysis 
TABLE VI 
Chi-Square Test of Silver Grain Distribution over Mitochondrial and Peroxisomal Profiles during Volumetric 
Expansion of the Peroxisomal Compartment 
Mitochondria  Peroxisomes 
Grain number  per profile  Grain number  per profile  Time after 
[aH]arginine 
injection  Grain number  0  1  2  3  4  X  z  0  1  2  3  X2 
6 h  Observed  9,080  1,853  169  17  1  3.5  3,565  642  33  0  11.8 
Theoretical  9,086.6  1,834.5  185.2  12.5  0.67  3,588.3  598.9  50.0  2.8 
1.5 days  Observed  9,919  1,363  74  3  0  3.6  4,034  598  22  1  10.2 
Theoretical  9,937.4  1,329.6  88.9  3.9  0.1  4,052.1  561.2  38.9  1.8 
3 days  Observed  11,538  1,832  110  12  0  10.6  5,713  831  30  1  14.3 
Theoretical  11,558.0  1,788.3  138.3  7.1  0.3  5,739.6  780.0  53.0  2.4 
For 1  ~ of freedom  )r  =  3.84; for 2  ~ of freedom,  X[.~ =  5.99. 
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cal findings on the biosynthetic pathway of specific 
peroxisomal constituents  at the subcellular level, 
i.e., to disclose the structural features of the cyto- 
solic catalase intermediate(s)  (38). 
Growth of Peroxisomes 
Assuming our hypothesis that the drug-induced 
expansion  of  the  peroxisomal  compartment  is 
mainly  the  result  of the de novo  formation  and 
subsequent growth of a special class of particles is 
correct, the problem of peroxisomal growth has to 
be  considered briefly.  The available  biochemical 
evidence suggests that the initially proposed "bud- 
ding and  growth" model (13)  may no longer be 
regarded as a plausible  interpretation  of the bio- 
synthetic pathway of PO in  the liver cells  of un- 
treated  rats  (12).  Instead,  it  has  been  proposed 
that  PO are  not individualized  organelles with a 
fixed life-span, but may continuously interchange 
material by means of interconnecting (ER) chan- 
nels (12, 60), or by fusional and/or fissional proc- 
esses  occurring  at  the  level  of the  peroxisomal 
particles  (40,  59).  Accordingly,  the  whole  PO 
population of a hepatocyte might be considered to 
represent a single metabolic pool, in which peroxi- 
somal  material  could  flow  unrestrictedly.  The 
most  plausible  interpretation  of the  results  pre- 
sented here does not concur with such an assump- 
tion. It was observed that after the administration 
of the  isotope,  the  specific label  density  of PO 
remained elevated as long as the drug was admin- 
istered  and then  declined rapidly (Fig.  13).  This 
conserved  radioactivity  was  associated  preferen- 
tially  with the larger PO, the smaller ones being 
less extensively labeled (Table III and Fig. 14). As 
the drug-induced expansion of PO progressed fur- 
ther,  the  frequency  peak  of  labeled  particles 
moved to larger size classes (Fig.  14), which dis- 
played a  high level of labeling (Table  III). Simi- 
larly, the limit of the smallest labeled particles was 
displaced  to  larger  diameter  classes  (Fig.  14). 
These findings suggest that the proliferation of a 
class  of larger  PO  is  the  outcome  of a  unique 
metabolic  process  initiated  and  maintained  by 
agents  endowed  with  a  PO-stimulating  capacity. 
The gradual and progressive nature  of this drug- 
induced shift in size and radioactivity is difficult to 
reconcile with  the hypothesis that  the whole PO 
population of the hepatocyte constitutes a homo- 
geneous  metabolic  compartment.  On  the  other 
hand, these observations are compatible with the 
expansion  of  a  particular  class  of  particles  by 
growth. 
In the context of this label shift to PO of a larger 
diameter, a methodological aspect of autoradiog- 
raphy  should  be  considered.  It  has  been  shown 
that,  through the spread of radiation,  smaller ra- 
dioactive  sources  occurring  in  autoradiographs 
might  be  at  a  disadvantage  in  comparison  with 
larger  ones  (66).  However,  the  data  given  by 
Salpeter and McHenry (66) indicate that, in view 
of the small average dimensional changes associ- 
ated  with  the  peroxisome  expansion,  this  size- 
dependent preferential labeling of larger particles 
could  only  have  influenced  our  determinations 
slightly. 
Disposal of Peroxisomes during 
the Recovery Period 
At least three pathways have been proposed for 
the  disposal  of the  excess of PO  formed during 
treatment  with  aryloxyisobutyric derivatives  (42, 
47,  72).  The  first  process  is  considered  to  be 
autophagic by nature,  whereas the second one is 
described as consisting of a "dissolution" or "atro- 
phy" of individual PO within the cytoplasmic ma- 
trix,  without  the  involvement  of  sequestering 
membranes.  A  third  breakdown  mechanism has 
been tentatively described as proceeding by means 
of a  retraction  of PO  contents  within  the  SER 
compartment (47); it  is conceivable that the two 
last-mentioned  processes are morphologically in- 
terconnected. Using cytochemical procedures, we 
have studied, during the reconstitution period, the 
disappearance  of the excess of PO formed in the 
presence of Su-13 437 (70). The results obtained 
could  be  interpreted  in  terms  of  the  first  two 
pathways  mentioned.  In  addition,  we  have  pre- 
sented evidence suggesting the possibility that the 
"dissolution" of PO (42, 72) might be assisted by 
acid-phosphatase-positive  elongated  cisternae; 
these structures were seen  to be appressed  to or 
intercalated  between  PO  displaying  a  matrix  of 
reduced electron density (70). Although we have 
not quantitatively assessed the parts played by the 
different structures tentatively involved in the de- 
struction  of PO, silver grains lying over both se- 
questered  and  "dissolving"  PO  were  rarely  ob- 
served.  Apparently,  the  intracellular  removal of 
the excess  PO proceeded gradually  (Figs.  5  and 
6); in  keeping with this observation, the specific 
number  and  volume  of dense  bodies,  including 
autophagic  vacuoles,  were  not  dramatically 
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4).  This observation  is at  variance with the find- 
ings reported  by Moody  and  Reddy  (47).  These 
authors noted a  significant increase of the iysoso- 
mal volume density in adult rat hepatocytes 4 days 
after withdrawal of Sail-42  348.  Nevertheless, it 
seems possible  that  in  the  neonatal  situation  the 
recovering  hepatocyte  is  capable  of  removing, 
within  a  few days,  a  large  number  of organelles 
without being compelled to build up an extensive 
destruction  apparatus.  Similar observations  were 
made in rat liver cells after the discontinuation of 
CPIB treatment (72), or during glucagon-induced 
autophagy  (16).  The  process  leading  to  the  de- 
struction  of  PO  must  obviously  entail  a  certain 
capacity to select PO of a  larger size out of a  PO 
population  which,  during  the  recovery  period, 
comprises an  increasing amount  of smaller parti- 
cles (Figs.  5  and  6).  Thus,  in  the  case  of Su-13 
437-treated  neonatal  rats,  the  breakdown  of the 
drug-induced  excess  of  PO  seems  not  to  be  a 
strictly random process such as has been suggested 
to occur in normal adult liver to explain the expo- 
nential decay kinetics of labeled peroxisomal pro- 
teins (12,  see also reference 54). 
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